UCB taps innovation to help Chinese patients
BELGIAN drugmaker UCB’s efforts to improve quality of life for people with severe diseases have benefited millions of Chinese patients in the past two decades.
The Brussels-based multinational biopharmaceutical company made its first foray into the Chinese market in 1996.
Since then, UCB China has fortified its presence by setting up head office in Shanghai, regional offices in Beijing, Chengdu and Guangzhou, and a manufacturing facility in Zhuhai, Guangdong province.
“UCB is committed to helping people in every country where we operate to live a better life and benefit from our innovative medicines,” Veronique Toully, head of operations for UCB China, told Shanghai Daily. “Our goal in China is to bring our innovative solutions as quickly as possible to Chinese patients.”
Committed to its slogan “Inspired by patients, driven by science,” in 2016 UCB will have brought a diversified line of products to more than five million Chinese patients suffering from epilepsy, anemia, allergy, pain and other immunology diseases. Investing more than 25 percent of its revenue in research and development every year, much higher than the industry average of 18 percent, the company is seeking to bring to patients a promising portfolio of innovative medicines targeting severe diseases and addressing unmet medical needs.
“Rather than expressing our business goals only in monetary terms, our ability to create value for patients and work with doctors to bring better solutions to patients is what makes UCB successful as a company,” Toully said.
“We are delivering on our promise through innovative medicines, education and information.”
As an illustration, during the past 10 years, UCB has been committed to raising awareness on epilepsy and teamed up with medical associations in China to improve public awareness of the disease. In 2016 alone, they have supported education programs implemented by their partners that have reached 15,000 Chinese patients suffering from epilepsy and their caregivers.
Since 2013, UCB is also supporting Project Hope in a three-year program called Rainbow Bridge (Epilepsy Children Care) with the objective to improve medical care for children with epilepsy and provide psychological support for their families.
“We will continue to support programs that raise epilepsy awareness among doctors, patients and the general public and to improve access to reliable information for all about the disease,” Toully said.
UCB is fully leveraging the connected environment in China and supporting digital education and information programs available on mobile devices through popular platforms in China including WeChat. They support patient-friendly education programs launched by medical associations for parents with young children, still with the objective to raise awareness about chronic diseases affecting Chinese youngest citizens.
- About Us
- |
- Terms of Use
- |
- RSS
- |
- Privacy Policy
- |
- Contact Us
- |
- Shanghai Call Center: 962288
- |
- Tip-off hotline: 52920043
- 沪ICP证:沪ICP备05050403号-1
- |
- 互联网新闻信息服务许可证:31120180004
- |
- 网络视听许可证:0909346
- |
- 广播电视节目制作许可证:沪字第354号
- |
- 增值电信业务经营许可证:沪B2-20120012
Copyright © 1999- Shanghai Daily. All rights reserved.Preferably viewed with Internet Explorer 8 or newer browsers.